These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36286658)

  • 41. Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies.
    Zhang Z; Zhang B; Wang X; Zhang X; Yang QX; Qing Z; Zhang W; Zhu D; Bi Y
    Diabetes Care; 2019 Jul; 42(7):1274-1283. PubMed ID: 31221697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Blood pressure variability and brain neuroimaging in patients with type 2 diabetes].
    Matveeva MV; Samoilova YG; Kudlay DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):90-96. PubMed ID: 35611906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of long-term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: A longitudinal cohort study.
    Yu JH; Kim REY; Park SY; Lee DY; Cho HJ; Kim NH; Yoo HJ; Seo JA; Kim SG; Choi KM; Baik SH; Shin C; Kim NH
    Diabetes Obes Metab; 2023 Apr; 25(4):1091-1100. PubMed ID: 36564910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Default Mode Network Connectivity and Related White Matter Disruption in Type 2 Diabetes Mellitus Patients Concurrent with Amnestic Mild Cognitive Impairment.
    Qi D; Wang A; Chen Y; Chen K; Zhang S; Zhang J; Li X; Ai L; Zhang Z
    Curr Alzheimer Res; 2017; 14(11):1238-1246. PubMed ID: 28413981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
    Hall JM; Lewis SJG
    Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
    Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
    J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of cognitive rehabilitation in people with type 2 diabetes: A study protocol for a randomized controlled trial.
    Cuevas H; Stuifbergen AK; Hilsabeck RC; Sales A; Wood S; Kim J
    PLoS One; 2023; 18(5):e0285553. PubMed ID: 37186584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic Effect of Serum Homocysteine and Diabetes Mellitus on Brain Alterations.
    Byeon G; Byun MS; Yi D; Lee JH; Jeon SY; Ko K; Jung G; Lee JY; Kim YK; Lee YS; Kang KM; Sohn CH; Lee DY;
    J Alzheimers Dis; 2021; 81(1):287-295. PubMed ID: 33749655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
    Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
    Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
    van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
    Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral Structure and Function in Stroke-free Patients with Atrial Fibrillation.
    Silva DS; Caseli BG; de Campos BM; Avelar WM; Lino APBL; Balthazar MLF; Figueiredo MJO; Cendes F; Pegoraro LFL; Coan AC
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105887. PubMed ID: 34102554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of folliculogenesis and oxidative stress parameters in type 1 diabetes mellitus women with different glycemic profiles.
    Tiselko AV; Misharina EV; Yarmolinskaya MI; Milyutina YP; Zalozniaia IV; Korenevsky AV
    Endocrine; 2024 Jun; ():. PubMed ID: 38842765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discrepancy Between Cognitive Test and Brain Imaging Results in Alzheimer's Disease Associated with Diabetes.
    Hanyu H; Koyama Y; Horita H; Aoki T; Sato T; Kanetaka H; Shimizu S; Hirao K
    Curr Alzheimer Res; 2022; 19(2):95-103. PubMed ID: 35227184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment.
    Rizzo MR; Barbieri M; Boccardi V; Angellotti E; Marfella R; Paolisso G
    J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1122-31. PubMed ID: 24671867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual-task performance is associated with brain MRI Morphometry in individuals with mild cognitive impairment.
    Grijalva C; Toosizadeh N; Sindorf J; Chou YH; Laksari K
    J Neuroimaging; 2021 May; 31(3):588-601. PubMed ID: 33783915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study of glycemic variability in patients with type 2 diabetes mellitus with obstructive sleep apnea syndrome using a continuous glucose monitoring system.
    Khaire SS; Gada JV; Utpat KV; Shah N; Varthakavi PK; Bhagwat NM
    Clin Diabetes Endocrinol; 2020; 6():10. PubMed ID: 32518676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus.
    Mehta D; Pimentel DA; Núñez MZ; Abduljalil A; Novak V
    Metabolism; 2014 Nov; 63(11):1390-7. PubMed ID: 25216926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.